Mood effects of the amino acids tryptophan and tyrosine

Abstract

Parker G, Brotchie H. Mood effects of the amino acids tryptophan and tyrosine.Objective: Reflecting increased scientific interest in any nutritional contribution to the onset and treatment of mood disorders, we overview research into two neurotransmitter precursors – the amino acids tryptophan and tyrosine – particularly examining whether any deficiency increases risk to depression and whether those amino acids have any antidepressant properties.Method: The theoretical relevance of the two amino acids was overviewed by considering published risk and intervention studies, technical papers and reviews.Results: There is some limited evidence, suggesting that depressed patients, especially those with a melancholic depression, have decreased tryptophan levels. Whether such findings reflect a causal contribution or are a consequence of a depressed state remains an open question. There is a small database supporting tryptophan preparations as benefitting depressed mood states. There is no clear evidence as to whether tyrosine deficiency contributes to depression, while the only randomized double‐blind study examining tyrosine supplementation did not show antidepressant benefit.Conclusion: Acute tryptophan depletion continues to provide a research tool for investigating the relevance of serotonin to depression onset. There is limited evidence that tryptophan loading is effective as a treatment for depression through its action of increasing serotonin production. Most clinical studies are dated, involve small sample sizes and/or were not placebo controlled. The development of the new serotonin reuptake inhibitor drugs seemingly signalled an end to pursuing such means of promoting increased serotonin as a treatment for depression. The evidence for tyrosine loading promoting catecholamine production as a possible treatment for depression appears even less promising, and depletion studies less informative.

Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands—A review

“…This treatment was reported to help in very small samples (Gelenberg et al, 1980;Goldberg, 1980), but a larger, randomized study was unable to replicate this result (Gelenberg et al, 1990). This led to the conclusion that treating depression with TYR is not very promising (Fernstrom, 2000;Parker and Brotchie, 2011). However, depression is a complex and varied disorder that likely has many subtypes defined by different etiologies (e.g.…”

The Neurobiological Pathogenesis of Poststroke Depression

“…Since the emotional behaviors are regulated by different neurotransmitters especially monoamines, the dysfunction of monoamines due to different conditions could result in different kinds of psychiatric symptoms including depression [44]. This amine hypothesis could be conceived as the supplement or further explanation of lesion location hypothesis when it is used to explain the pathogenesis of PSD or vascular depression [28].…”

Beyond Pharmacotherapy: Understanding the Links between Obesity and Chronic Mental Illness

“…It may be that the ability of certain foods to temporarily boost mood can create a behavioural cycle where food is consumed to control feelings of sadness. 120 The relation between trauma and weight is especially evident during weight loss treatment programs and in bariatric surgery programs, a past history of trauma can be a harbinger of postoperative problems. 121 Food and weight gain in response to abuse may be related to a desire to become bigger to be able to defend against an abuser, it may have been a way to change appearance when a person inaccurately felt they were somehow provoking the abuse, or it may have become a surrogate comfort mechanism when appropriate supports failed.…”